Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach

BACKGROUND: Biological disease-modifying antirheumatic drugs (bDMARDs) used in second-line treatment of rheumatoid arthritis (RA) are administered parenterally. However, so-called targeted synthetic DMARDs (tsDMARDs) – developed more recently – offer alternative (ie, oral) administration forms in se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Patient Prefer Adherence
Autors principals: Alten, Rieke, Krüger, Klaus, Rellecke, Julian, Schiffner-Rohe, Julia, Behmer, Olaf, Schiffhorst, Guido, Nolting, Hans-Dieter
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5098563/
https://ncbi.nlm.nih.gov/pubmed/27843301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S117774
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars